Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1993-05-03
1995-08-22
Lacey, David L.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241451, 4241581, 4241781, 5303911, 53038825, 530324, 5303873, 514 12, A61K 39395, C07K 1600, C07K 1618, C07K 750
Patent
active
054438276
ABSTRACT:
A chimeric molecule that contains a fibrin-binding portion of an antibody covalently linked to an inhibitor of thrombin, which molecule is administered to inhibit thrombus formation and growth.
REFERENCES:
patent: 4164560 (1979-08-01), Folkman et al.
patent: 4767742 (1988-08-01), Dodt et al.
patent: 4927916 (1990-05-01), Matsueda et al.
patent: 5116613 (1992-05-01), Haber et al.
patent: 5118790 (1992-06-01), Winant et al.
patent: 5120834 (1992-06-01), Gargan et al.
Hui, K. Y. et al., Science, 222:1129-1131, 1983.
Markwardt, F., Biomed Biochim. Acta, 44(Jul. 8):1007-1013, 1985.
Bode, C. et al., Clin. Cardiol, 13:375-381, 1990.
Waldmann, T. A., Science, 252:1657-1662, 1991.
Bode, C. et al., Circulation, 90:1956-1963, 1994.
Cadroy, Yves et al., J. Lab. Clin. Med., 114:349-57, 1989.
Hanson, Stephen R. et al., Arteriosclerosis, 5:595-603, Nov./Dec. 1985.
Schneider, P. A. et al., J. Vasc. Surg., 11:365-372, 1990.
Sheffield, W. P., et al., "Molecular Cloning and Expression of Rabbit Antithrombin III", Blood, vol. 79, No. 9, May 1, 1992; pp. 2330-2339.
Kim, B., et al., "Antithrombotic effect of .beta.,.beta.-monochloromethylene diadenosine 5',5'"-P1, P-4-tetraphosphate", Proc. Natl. Acad. Sci USA, vol. 89, Nov. 1992, pp. 11058.
Kettner, C., et al., "The Selective Inhibition of Thrombin by Peptides of Boroarginine", Journal of Biological Chemistry, vol. 265, No. 30, Oct. 25, 1990, pp. 18289-18297.
Kelly, A., et al., "Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin", Medical Sciences, vol. 89, Jul. 1992, pp. 6040-6044.
Mor, A., et al., "Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin", Bio. et Biophysica Acta, 1038, 1990, pp. 119-124.
Schmaier, A. H., et al., "PPack-Thrombin is a Noncompetitive Inhibitor of .alpha.-Thrombin Binding to Human Platelets", Thrombosis Research, vol. 67, 1992, pp. 479-489.
Bagdy, D. et al., "Comparative Studies in vitro and Ex Vivo on the Anticoagulant Effects of a Reversible and an Irreversible Tripeptide Inhibitor of Thrombin", Thrombosis Research, vol. 67, 1992, pp. 221-231.
Sturzebecher, J., et al., "Interactions of Thrombin with Benzamidine-based Inhibitors", Biol. Chem. Hoppe-Seyler, vol. 373, 1992, pp. 491-496.
Bode, W., et al., "Geometry of binding of the benzamidine- and arginine-based inhibitors Nx-(2-naphthyl-sulphonyl-glycyl) . . . to human .alpha.-thrombin", Eur. J. Biochem, vol. 193, 1990, pp. 175-182.
DiMaio, J., et al. "A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond", Fed. of Eur. Biochemical Societies, vol. 282, No. 1, Apr. 1991, pp. 47-52.
DiMaio, J., et al., "Synthesis of a Homologous Series of Ketomethylene Arginyl Pseudodipeptides and Appl. to Low Molecular Weight Hirudin-Like Thrombin Inhibitors", J. Med. Chem., vol. 33, 1992, pp. 3331-3341.
Runge, M. S., et al., "A recombinant chimeric plasminogen activator with high affinity for fibrin has incr. thrombolytic potency in vitor and in vivo", Proc. Natl. Acad. Sci USA, vol. 88, 1991, pp. 10337-10341.
Dodt, J., et al., "The complete amino acid sequence of hirudin, a thrombin specific inhibitor", Fed. of Eur. Biochemical Societies, vol. 165, No. 2, 1984, pp. 180-185.
Runge, M. S., et al., "Conjugation to an Antifibrin Monoclonal Antibody Enhances the Fibrinolytic Potency of Tissue Plasminogen Activator in Vitro", Biochemistry, vol. 27, 1988, pp. 1153-1157.
Bode, C., et al., "Characterization of an Antibody-Urokinase Conjugate", J. of Biological Chemistry, vol. 262, No. 22, 1987, pp. 10819-10823.
United States Serial No. 08/096,173, filed Jul. 26, 1993 (copy not available to us and not enclosed).
Bode Christoph
Haber Edgar
Runge Marschall S.
Emory University
Lacey David L.
Loring Susan A.
President and Fellows of Harvard College
LandOfFree
Fibrin-targeted inhibitors of thrombin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrin-targeted inhibitors of thrombin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrin-targeted inhibitors of thrombin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2140340